CSIMarket
 


Penumbra Inc   (PEN)
Other Ticker:  
 
 

PEN's Net Cash Flow Growth by Quarter and Year

Penumbra Inc 's Net Cash Flow results by quarter and year




PEN Net Cash Flow (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December 66.73 4.54 -6.91 -10.45
III Quarter September -13.41 -3.39 -15.99 -54.27
II Quarter June 19.48 -9.93 26.65 61.93
I Quarter March 24.83 8.78 -14.04 -0.32
FY   97.63 0.00 -10.29 -3.11



PEN Net Cash Flow fourth quarter 2023 Y/Y Growth Comment
Penumbra Inc achieved in the fourth quarter 2023, above Company average Net Cash Flow surge of 1369.8% year on year, to $ 66.73 millions.

Among companies who have reported fourth quarter 2023 results in the Medical Equipment & Supplies industry only one Company has achieved higher year on year Net Cash Flow results in the fourth quarter 2023. While Penumbra Inc ' s Net Cash Flow doubling of 1369.8% ranks overall at the positon no. 41 in the fourth quarter 2023.




PEN Net Cash Flow ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December 1369.8 % - - -
III Quarter September - - - -
II Quarter June - - -56.97 % -
I Quarter March 182.8 % - - -
FY   - - - -

Financial Statements
Penumbra Inc 's fourth quarter 2023 Net Cash Flow $ 66.73 millions PEN's Income Statement
Penumbra Inc 's fourth quarter 2022 Net Cash Flow $ 4.54 millions Quarterly PEN's Income Statement
New: More PEN's historic Net Cash Flow Growth >>


PEN Net Cash Flow (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June -21.55 % - - -
I Quarter March 446.92 % - - -
FY (Year on Year)   - - - -




Net Cash Flow fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #2
Healthcare Sector #4
Overall #41

Net Cash Flow Y/Y Growth Statistics
High Average Low
1371.42 % 259.7 % -100 %
(Dec 31 2023)   (Mar 31 2018)
Net Cash Flow fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #2
Healthcare Sector #4
Overall #41
Net Cash Flow Y/Y Growth Statistics
High Average Low
1371.42 % 259.7 % -100 %
(Dec 31 2023)   (Mar 31 2018)

Net Cash Flow by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Penumbra Inc 's Q/Q Net Cash Flow Growth


Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


PEN's IV. Quarter Q/Q Net Cash Flow Comment
IV. Quarter 2023Periodic Penumbra Inc in the factors net cash outflow of $ 66.73 millionsPeriodic factors have added to Penumbra Inc 's rebound to positive trends, as PEN deliverNet Cash Flow of $ 66.73 millions in the IV. Quarter 2023 emanate net cash outflow-13.41 millions in the third quarter. Penumbra Inc announced in the IV. Quarter 2023 Net Cash Flow of $ 66.73 millions compare to net cash outflow recorded in previos quarter.

Within Medical Equipment & Supplies industry Penumbra Inc achieved highest sequential Net Cash Flow growth. While Penumbra Inc 's Net Cash Flow growth quarter on quarter, overall rank is .


Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


PEN's IV. Quarter Q/Q Net Cash Flow Comment
IV. Quarter 2023Periodic Penumbra Inc in the factors net cash outflow of $ 66.73 millionsPeriodic factors seem to have led to Penumbra Inc 's rebound to profitability, as PEN postNet Cash Flow of $ 66.73 millions in the IV. Quarter 2023 emerging from net cash outflow-13.41 millions in the third quarter. Penumbra Inc announced in the IV. Quarter 2023 Net Cash Flow of $ 66.73 millions compare to net cash outflow recorded in previos quarter.

Within Medical Equipment & Supplies industry Penumbra Inc achieved highest sequential Net Cash Flow growth. While Penumbra Inc 's Net Cash Flow growth quarter on quarter, overall rank is .


Penumbra Inc 's 12 Months Net Cash Flow Growth Year on Year


Net Cash Flow TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative Net Cash Flow 12 Months Ending $ 97.63 $ 35.43 $ 45.45 $ 16.05 $ 0.00
Y / Y Net Cash Flow Growth (TTM) - - - 28.05 % -
Year on Year Net Cash Flow Growth Overall Ranking # 200 # 286 # 245 # 259 # 0
Seqeuential Net Cash Flow Change (TTM) 175.52 % -22.04 % 183.27 % - -
Seq. Net Cash Flow Growth (TTM) Overall Ranking # 128 # 210 # 187 # 0 # 0




Cumulative Net Cash Flow growth Comment
Penumbra Inc saw improvement in Net Cash Flow growth trend, posting cumulative 12 months Net Cash Flow growth of 1369.8% year on year, to $ 98 millions if the fiscal year would have ended in Dec 31 2023.
Penumbra Inc 's trailing twelve months Net Cash Flow growth was higher than company's average -41.57% and higher than % growth in Sep 30 2023.
But sequential rise was less at 175.52 % from $35.43 millions reported in twelve months ending a quarter Sep 30 2023.
Still this was confirmation of strength, as the usual Q/Q TTM gain is at -41.57%.

Among companies within the Healthcare sector 18 other companies have achieved higher trailing twelve month Net Cash Flow growth. While Total ranking has impoved so far to 200, from total ranking in previous quarter at 286.

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
270.01 %
-41.57 %
-191.22 %
 

Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 3
Healthcare Sector # 19
Overall # 200

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
270.01 %
-41.57 %
-191.22 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 3
Sector # 15
S&P 500 # 128
Cumulative Net Cash Flow growth Comment
Penumbra Inc saw improvement in Net Cash Flow growth trend, posting cumulative 12 months Net Cash Flow growth of 1369.8% year on year, to $ 98 millions if the fiscal year would have ended in Dec 31 2023.
Penumbra Inc 's trailing twelve months Net Cash Flow growth was higher than company's average -41.57% and higher than % growth in Sep 30 2023.
But from twelve months ended Sep 30 2023 rise was less at 175.52 % from $35.43 millions reported in the period from Sep 30 2023 to Dec 31 2022.
Yet it was evidence of convincing trend, as the usual sequential gain is at -41.57%.
The growth is even stronger sequentially exhibited at 175.52 % increase from $35.43 millions in the period from Sep 30 2023 to Dec 31 2022.

Among companies within the Healthcare sector 18 other companies have achieved higher trailing twelve month Net Cash Flow growth. While Total ranking has impoved so far to 200, from total ranking in previous quarter at 286.

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
270.01 %
-41.57 %
-191.22 %
 


Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 3
Healthcare Sector # 19
Overall # 200

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
270.01 %
-41.57 %
-191.22 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 3
Sector # 15
S&P 500 # 128




Other Net Cash Flow Growth
Medical Equipment & Supplies Industry Net Cash Flow Growth Trends and Statistics
Healthcare Sector Net Cash Flow Growth Statistics
Net Cash Flow Growth Trends for overall market
PEN's Net Cash Flow Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Growth
Lowest Ranking Net Cash Flow Growth
Net Cash Flow Growth for PEN's Competitors
Net Cash Flow Growth for Penumbra Inc 's Suppliers
Net Cash Flow Growth for PEN's Customers

You may also want to know
PEN's Annual Growth Rates PEN's Profitability Ratios PEN's Asset Turnover Ratio PEN's Dividend Growth
PEN's Roe PEN's Valuation Ratios PEN's Financial Strength Ratios PEN's Dividend Payout Ratio
PEN's Roa PEN's Inventory Turnover Ratio PEN's Growth Rates PEN's Dividend Comparisons



Companies with similar Net Cash Flow doubling for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Net Cash Flow for the quarter ending Dec 31 2023
Sanuwave Health Inc 1,612.20%$ 1,612.195 millions
Penumbra Inc 1,371.42%$ 1,371.422 millions
Edgewise Therapeutics inc 1,355.09%$ 1,355.093 millions
Propanc Biopharma Inc 1,180.02%$ 1,180.020 millions
Globus Medical Inc 1,055.40%$ 1,055.402 millions
Idexx Laboratories Inc814.26%$ 814.256 millions
Orasure Technologies Inc730.47%$ 730.473 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com